NO PRICE IS TOO LOW FOR A BEAR OR TOO HIGH FOR A BULL
As we all know India is going through a tough period because of CORONA VIRUS and all the industries are facing difficulty but it is a good opportunity for the investors to invest in Pharmaceuticals companies because in this period the basic need is Healthcare and every government is depending or improving healthcare of their country. For India here is the list of few companies which can give you decent amount of profit in this lockdown period.
Cadila Health: Cadila Healthcare Ltd. is listed in both NSE/BSE. It is an Indian pharmaceutical company headquartered at Ahmedabad (Gujarat) of western India. Cadila Healthcare Ltd. is one of the leading pharmaceutical companies in India, with INR 119.05 Billion revenue. It is a manufacturer of generic drugs. Its current share value is INR 353.75.
Divis Labs: Divis Laboratories Ltd. is listed in Both NSE/BSE. Divis Laboratories is one of famous laboratories in India having more than 11000 employees, 3 R&D research center and they are working form the last 29 years that shows that they are really good what they are doing. As we know that Indian government is giving free test facility for the private labs it became a golden opportunity for them. Its current share value is INR 2341.20.
Biocon: Biocon Limited is an Indian biopharmaceutical make many medicine sell all over India and other 120 countries as well there headquates is situated in Banguluru. Biocon is also having other Subsidries like Biocon Acdamy etc. its current market value is INR 340.55.
The Above article is written by Shirish Gupta